http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#head http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#assertion http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#provenance http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#assertion http://bio2rdf.org/drugbank:DB00582 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00582_DB00918 http://bio2rdf.org/drugbank:DB00918 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00582_DB00918 http://bio2rdf.org/drugbank_resource:DB00582_DB00918 http://purl.org/dc/terms/identifier drugbank_resource:DB00582_DB00918 http://bio2rdf.org/drugbank_resource:DB00582_DB00918 http://purl.org/dc/terms/title DDI between Voriconazole and Almotriptan - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of almotriptan by decreasing its metabolism. The initial and maximum doses should not exceed 6.25 mg and 12.5 mg, respectively during concomitant therapy. Concomitant therapy should be avoided in patients with impaired hepatic or renal function. http://bio2rdf.org/drugbank_resource:DB00582_DB00918 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00582_DB00918 http://www.w3.org/2000/01/rdf-schema#label DDI between Voriconazole and Almotriptan - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of almotriptan by decreasing its metabolism. The initial and maximum doses should not exceed 6.25 mg and 12.5 mg, respectively during concomitant therapy. Concomitant therapy should be avoided in patients with impaired hepatic or renal function. [drugbank_resource:DB00582_DB00918] http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#provenance http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#signature.MCwCFCJhFlCNfQT7 http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#signature.MCwCFCJhFlCNfQT7 http://purl.org/nanopub/x/hasSignature MCwCFCJhFlCNfQT7etKd39hc/h37Y46eAhQDGTjdc1o1CBmehLkwHvwHn75Ksg== http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#signature.MCwCFCJhFlCNfQT7 http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://purl.org/dc/terms/created 2018-03-30T11:12:34.133+02:00 http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc#signature.MCwCFCJhFlCNfQT7 http://bio2rdf.org/drugbank_resource:DB00582_DB00918_nanopub.RAK5qn0vqjaaES-fR-NG93byFKo2jqEAZELpnsHHBTBfc http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234